Results 21 to 30 of about 2,860,326 (352)
Viral antibodies in infectious mononucleosis [PDF]
Patients with Epstein-Barr virus (EBV) infectious mononucleosis (IM) usually develop heterophilic antibodies and some autoantibodies. Antibodies to rubella, measles, adeno-, entero-, herpes simplex, cytomegalo- and varicella-zoster viruses were titrated in sera from IM patients and matched healthy controls using the complement fixation test (CFT) and ...
May Britt Kalvenes+5 more
openaire +3 more sources
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
The SARS-CoV-2 antibody neutralization response and its evasion by emerging viral variants are unknown. Antibody immunoreactivity against SARS-CoV-2 antigens and Spike variants, inhibition of Spike-driven virus-cell fusion, and infectious SARS-CoV-2 ...
F. Tea+26 more
semanticscholar +1 more source
Efficient evolution of human antibodies from general protein language models
A general protein language model guides protein evolution with 20 or fewer variants needed for testing. Natural evolution must explore a vast landscape of possible sequences for desirable yet rare mutations, suggesting that learning from natural ...
Brian L. Hie+8 more
semanticscholar +1 more source
Background: The assessment of antibody responses to severe acute respiratory syndrome coronavirus-2 is potentially confounded by exposures to flaviviruses. The aims of the present research were to determine whether anti-dengue antibodies affect the viral
Simon D. Lytton+14 more
doaj +1 more source
Engineered antibodies to combat viral threats [PDF]
As the COVID-19 pandemic rages globally, interest in antiviral treatments has never been higher. Antibodies are key defence components, and engineering them to better exploit their natural functions might boost therapeutic options. Modification of the antibody Fc domain boosts defence responses.
Cragg, Mark, Yu, Xiaojie
openaire +4 more sources
Protective mechanisms of nonneutralizing antiviral antibodies.
Antibodies that can bind to viruses but are unable to block infection in cell culture are known as "nonneutralizing antibodies." Such antibodies are nearly universally elicited following viral infection and have been characterized in viral infections ...
Tawny L Chandler+4 more
doaj +1 more source
Viral Antibodies in Chronic Fatigue Syndrome [PDF]
Item does not contain ...
Swanink, C.M.A.+6 more
openaire +6 more sources
Complete mapping of viral escape from neutralizing antibodies. [PDF]
Identifying viral mutations that confer escape from antibodies is crucial for understanding the interplay between immunity and viral evolution. We describe a high-throughput approach to quantify the selection that monoclonal antibodies exert on all ...
Michael B Doud+2 more
doaj +1 more source
Viral interference with antibody and complement
Viruses have evolved strategies to evade immunity mediated by antibody and complement. Herpesviruses and coronaviruses encode IgG Fc binding proteins that inhibit IgG activity, enabling the virus or infected cell to escape antibody attack. Herpesviruses, vaccinia virus and HIV-1 have the capacity to interfere with complement, either by incorporation of
Harvey M. Friedman+2 more
openaire +2 more sources
The objective of the present study was to evaluate the true positivity among people, whose results of initial testing of nasopharyngeal swabs (NPS) showed a very low viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Zoe Florou+7 more
doaj +1 more source